EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access

A double-blind, randomized, placebo-controlled, pilot clinical trial examining buspirone as an adjunctive medication during buprenorphine-assisted supervised opioid withdrawal.

Cecilia L Bergeria iD, Hongjun Tan iD, Denis Antoine iD, Elise M Weerts iD, Andrew S Huhn iD, J Gregory Hobelmann, Kelly E Dunn

Experimental and Clinical Psychopharmacology · 2023-02 · 31 (1) · 194-203

DOI: 10.1037/pha0000550 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Experimental and Clinical Psychopharmacology, 2023-02. Verfasst von Cecilia L Bergeria und 6 weiteren Autor:innen. Beteiligte Einrichtung: Behavioral Pharmacology Research Unit, Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine. Hauptthemen laut MEDLINE: Buprenorphine, Opioid-Related Disorders, Substance Withdrawal Syndrome. Die Arbeit wurde bisher 5-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDA NIH HHS, Dalio Philanthropies, Canopy Growth Corporation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BuprenorphineOpioid-Related DisordersSubstance Withdrawal SyndromeHumansAnalgesics, OpioidBuspironeNarcotic AntagonistsNarcoticsAnalgesicsDouble-Blind MethodTreatment Outcome

Substanzen

BuprenorphineAnalgesics, OpioidBuspironeNarcotic AntagonistsNarcoticsAnalgesics

Autor:innen und Institutionen

  • Behavioral Pharmacology Research Unit, Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine.

ORCID-Profile: Cecilia L Bergeria, Hongjun Tan, Denis Antoine, Elise M Weerts, Andrew S Huhn

Förderung

  • NIDA NIH HHS
  • Dalio Philanthropies
  • Canopy Growth Corporation
  • Ashley Addiction Treatment

Zitieren

APA

Bergeria, C. L., Tan, H., Antoine, D., Weerts, E. M., Huhn, A. S., Hobelmann, J. G., & Dunn, K. E. (2023). A double-blind, randomized, placebo-controlled, pilot clinical trial examining buspirone as an adjunctive medication during buprenorphine-assisted supervised opioid withdrawal. Experimental and Clinical Psychopharmacology, 31(1), 194-203. https://doi.org/10.1037/pha0000550

Vancouver

Bergeria CL, Tan H, Antoine D, Weerts EM, Huhn AS, Hobelmann JG, et al. A double-blind, randomized, placebo-controlled, pilot clinical trial examining buspirone as an adjunctive medication during buprenorphine-assisted supervised opioid withdrawal. Experimental and Clinical Psychopharmacology. 2023;31(1):194-203. doi:10.1037/pha0000550

BibTeX
@article{Bergeria2023,
  author = {Bergeria, Cecilia L and Tan, Hongjun and Antoine, Denis and Weerts, Elise M and Huhn, Andrew S and Hobelmann, J Gregory and Dunn, Kelly E},
  title = {A double-blind, randomized, placebo-controlled, pilot clinical trial examining buspirone as an adjunctive medication during buprenorphine-assisted supervised opioid withdrawal},
  journal = {Experimental and Clinical Psychopharmacology},
  year = {2023},
  volume = {31},
  number = {1},
  pages = {194--203},
  doi = {10.1037/pha0000550}
}
Kostenlos starten →